Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Praxis Precision Medicines Inc
(NQ:
PRAX
)
38.97
-1.08 (-2.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
354,480
Open
39.88
Bid (Size)
38.71 (1)
Ask (Size)
49.00 (1)
Prev. Close
40.05
Today's Range
38.74 - 40.88
52wk Range
0.8500 - 67.21
Shares Outstanding
44,712,538
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
May 31, 2024
Via
Benzinga
Performance
YTD
+86.46%
+86.46%
1 Month
-13.80%
-13.80%
3 Month
-28.59%
-28.59%
6 Month
+139.52%
+139.52%
1 Year
+3542.06%
+3542.06%
More News
Read More
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
May 17, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Recap: Praxis Precision Medicine Q4 Earnings
March 05, 2024
Via
Benzinga
Critical Insights From Praxis Precision Medicine Analyst Ratings: What You Need To Know
May 16, 2024
Via
Benzinga
PRAX Stock Earnings: Praxis Precision Medicine Misses EPS, Misses Revenue for Q1 2024
May 13, 2024
Via
InvestorPlace
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 13, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024
May 10, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
April 12, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines to Participate in Upcoming April Conferences
April 05, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering
March 28, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
March 27, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 26, 2024
Via
Benzinga
Why Praxis Precision Medicines Stock Is Trading Higher Tuesday
March 26, 2024
Via
Benzinga
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
March 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Praxis, A Top 1% Stock, Soars To Year-High After Epilepsy Treatment Scores Big
March 26, 2024
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 26, 2024
Via
Benzinga
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients
March 26, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines to Host PRAX-628 Program Update
March 25, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
PRAX Stock Earnings: Praxis Precision Medicine Beats EPS, Beats Revenue for Q4 2023
March 05, 2024
Via
InvestorPlace
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
March 05, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines to Participate in TD Cowen’s 44th Annual Health Care Conference
March 01, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2024
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.